Cingulate
(NASDAQ) CING
Cingulate Financials at a Glance
Market Cap
$73.96M
Revenue (TTM)
$0.00
Net Income (TTM)
$22.45M
EPS (TTM)
$-4.35
P/E Ratio
-1.46
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.33
Volume
10,521
Open
$6.88
Price
$6.33
Volume
10,521
Open
$6.88
Previous Close
$6.33
Daily Range
$6.20 - $6.88
52-Week Range
$3.20 - $11.89
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.33
Volume
10,521
Open
$6.88
Previous Close
$6.33
Daily Range
$6.20 - $6.88
52-Week Range
$3.20 - $11.89
CING News
CING: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cingulate
Industry
Pharmaceuticals
Sector
Health CareEmployees
14
CEO
Shane J. Schaffer, PharmD
Website
www.cingulate.comHeadquarters
Kansas City, KS 66205, US
CING Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-446%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-68.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$73.96M
Shares Outstanding
11.63M
Volume
10.52K
Short Interest
0.00%
Avg. Volume
458.88K
Financials (TTM)
Gross Profit
$540.89K
Operating Income
$19.94M
EBITDA
$19.40M
Operating Cash Flow
$17.25M
Capital Expenditure
$162.14K
Free Cash Flow
$17.41M
Cash & ST Invst.
$10.95M
Total Debt
$8.79M
Cingulate Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$419.06K
+361.4%
Gross Margin
0.00%
N/A
Market Cap
$73.96M
N/A
Market Cap/Employee
$5.69M
N/A
Employees
13
N/A
Net Income
$6.52M
-6.3%
EBITDA
$3.88M
+35.0%
Quarterly Fundamentals
Net Cash
$2.17M
-69.5%
Accounts Receivable
$8.01K
-69.6%
Inventory
$0.00
N/A
Long Term Debt
$2.25M
-7.6%
Short Term Debt
$6.53M
+145.5%
Return on Assets
-1.49%
N/A
Return on Invested Capital
-4.19%
N/A
Free Cash Flow
$13.64B
+318861.1%
Operating Cash Flow
$13.63B
+334223.0%